---
title: "Jazz Pharma director Bruce C. Cozadd disposes of 6,000 shares for $1.44 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291849439.md"
description: "Jazz Pharmaceuticals director Bruce C. Cozadd sold 6,000 ordinary shares on July 1 at $240.47 per share, totaling $1.44 million. The transaction was executed under a Rule 10b5-1 trading plan. Following the sale, his direct holdings decreased to 366,682 shares."
datetime: "2026-07-06T22:23:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291849439.md)
  - [en](https://longbridge.com/en/news/291849439.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291849439.md)
generator: "portal-rs"
---

# Jazz Pharma director Bruce C. Cozadd disposes of 6,000 shares for $1.44 million

-   Jazz Pharmaceuticals director Bruce C. Cozadd sold 6,000 ordinary shares on July 1 at USD 240.47 each. \* His direct holding fell to 366,682 ordinary shares following the transaction. \* The sale was executed under a Rule 10b5-1 trading plan. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193210-26-000016), on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [JAZZ.US](https://longbridge.com/en/quote/JAZZ.US.md)

## Related News & Research

- [Jazz Pharma CEO Renee D. Gala disposes of ordinary shares worth $970,664.07](https://longbridge.com/en/news/298641896.md)
- [JAZZ: Strong commercial execution and pipeline innovation drive robust growth and future potential](https://longbridge.com/en/news/298495735.md)
- [JAZZ: Record growth, new launches, and AI-driven strategies fuel rare disease expansion and raised outlook](https://longbridge.com/en/news/298625568.md)
- [Kohl’s COO Elliott Rodgers files initial beneficial ownership statement (Form 3)](https://longbridge.com/en/news/298641208.md)
- [Belite Bio CFO Chuang Hao-Yuan sells USD 8.85 million in common shares](https://longbridge.com/en/news/298514237.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**